Not Yet Recruiting
Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer
NCT06192680
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
- Locations
-
Not specified